Patents Assigned to LaZure Technologies, LLC
  • Patent number: 9603654
    Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: March 28, 2017
    Assignee: LaZure Technologies, LLC.
    Inventor: Larry Azure
  • Patent number: 8915911
    Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or selective ablation of target tissue regions, including selective ablation of cancerous cells and solid tumors. A method of the present invention includes delivering an electric field to a tissue, including positioning an electrode within a target tissue region comprising cancerous cells, and applying an alternating electrical current to the target tissue so as to non-thermally ablate cancerous cells of the target tissue region around the electrodes.
    Type: Grant
    Filed: April 13, 2010
    Date of Patent: December 23, 2014
    Assignee: LaZure Technologies, LLC
    Inventor: Larry Azure
  • Patent number: 8880195
    Abstract: Transurethral systems and methods for delivering electrical energy and controlled, mild heating to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning an elongate urethral probe having an expandable member with electrode elements at a target location in the patient's urethra, and inflating or expanding at the target location. Secondary electrodes are positioned within or adjacent to the prostate tissue and spaced from the electrode elements of the expandable member, and an alternating electrical current flow is established between the electrode elements of the expandable member and the one or more secondary electrodes. Current delivery can be selected so as to destroy or ablate cancerous cells of the prostate tissue.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: November 4, 2014
    Assignee: LaZure Technologies, LLC
    Inventor: Larry Azure
  • Publication number: 20140303613
    Abstract: Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation.
    Type: Application
    Filed: March 31, 2014
    Publication date: October 9, 2014
    Applicants: LaZure Scientific, Inc., LaZure Technologies, LLC
    Inventors: Larry Azure, Charles E. Hill, Andrew L. Azure
  • Patent number: 8728139
    Abstract: Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: May 20, 2014
    Assignees: LaZure Technologies, LLC, LaZure Scientific, Inc.
    Inventors: Larry Azure, Charles E. Hill, Andrew L. Azure
  • Publication number: 20140100565
    Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.
    Type: Application
    Filed: October 2, 2013
    Publication date: April 10, 2014
    Applicant: LaZure Technologies, LLC.
    Inventor: Larry Azure
  • Patent number: 8562602
    Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: October 22, 2013
    Assignee: Lazure Technologies, LLC
    Inventor: Larry Azure
  • Publication number: 20120232550
    Abstract: The present invention provides systems, devices and related methods for applying electric fields for cancerous cell destruction and tissue ablation. A method can include advancing an ablation probe into a patient; deploying a guide from the delivery member along a guide tissue penetration path, deploying an electrode from the guide along an electrode tissue penetration path, and establishing current flow within the target tissue.
    Type: Application
    Filed: January 5, 2012
    Publication date: September 13, 2012
    Applicants: LaZure Technologies, LLC, LaZure Scientific, Inc.
    Inventor: Larry Azure
  • Patent number: 8109926
    Abstract: The present invention provides systems, devices and related methods for applying electric fields for cancerous cell destruction and tissue ablation. A method can include advancing an ablation probe into a patient; deploying a guide from the delivery member along a guide tissue penetration path, deploying an electrode from the guide along an electrode tissue penetration path, and establishing current flow within the target tissue.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: February 7, 2012
    Assignees: Lazure Scientific, Inc., Lazure Technologies, LLC
    Inventor: Larry Azure
  • Publication number: 20110060393
    Abstract: Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation.
    Type: Application
    Filed: April 16, 2010
    Publication date: March 10, 2011
    Applicants: LaZure Technologies, LLC, LaZure Scientific, Inc.
    Inventors: Larry Azure, Charles E. Hill, Andrew L. Azure
  • Publication number: 20110015630
    Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or selective ablation of target tissue regions, including selective ablation of cancerous cells and solid tumors. A method of the present invention includes delivering an electric field to a tissue, including positioning an electrode within a target tissue region comprising cancerous cells, and applying an alternating electrical current to the target tissue so as to non-thermally ablate cancerous cells of the target tissue region around the electrodes.
    Type: Application
    Filed: April 13, 2010
    Publication date: January 20, 2011
    Applicant: LaZure Technologies, LLC
    Inventor: Larry Azure
  • Patent number: 7722606
    Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or selective ablation of target tissue regions, including selective ablation of cancerous cells and solid tumors. A method of the present invention includes delivering an electric field to a tissue, including positioning an electrode within a target tissue region comprising cancerous cells, and applying an alternating electrical current to the target tissue so as to non-thermally ablate cancerous cells of the target tissue region around the electrodes.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: May 25, 2010
    Assignee: LaZúre Technologies, LLC
    Inventor: Larry Azure
  • Publication number: 20100100093
    Abstract: Methods and systems for delivering electrical energy for controlled heating or hyperthermia to a target tissue of a patient for destruction of cancerous cells or tissue.
    Type: Application
    Filed: September 16, 2009
    Publication date: April 22, 2010
    Applicant: LaZure Technologies, LLC.
    Inventor: Larry Azure
  • Patent number: 7680543
    Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and ablation (e.g., non-thermal ablation) of target tissues, including cancerous cells and solid tumors. A method of the present invention can include applying an alternating current to a target tissue and removing ablated or liquefied tissue from the target tissue region.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: March 16, 2010
    Assignee: LaZure Technologies, LLC
    Inventor: Larry Azure
  • Publication number: 20090076496
    Abstract: Methods and systems for delivering electrical energy and controlled, mild hyperthermia to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning a plurality of electrodes in a target tissue region comprising the prostate tissue, and establishing an alternating electrical current flow through a volume of the prostate tissue to induce mild heating and destruction of cancerous cells in the volume.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicant: LaZure Technologies LLC.
    Inventor: Larry Azure
  • Publication number: 20090076494
    Abstract: Transurethral systems and methods for delivering electrical energy and controlled, mild heating to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning an elongate urethral probe having an expandable member with electrode elements at a target location in the patient's urethra, and inflating or expanding at the target location. Secondary electrodes are positioned within or adjacent to the prostate tissue and spaced from the electrode elements of the expandable member, and an alternating electrical current flow is established between the electrode elements of the expandable member and the one or more secondary electrodes. Current delivery can be selected so as to destroy or ablate cancerous cells of the prostate tissue.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicant: LaZure Technologies, LLC
    Inventor: Larry Azure
  • Publication number: 20090076500
    Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or mild hyperthermia, and preferential or selective ablation of cancerous cells of target tissue regions. A method can include, for example, advancing a probe comprising a plurality of electrodes to a target tissue region comprising cancerous cells, and deploying the plurality of electrodes from a distal portion of a probe, and applying an alternating current so as to provide one or more electric fields extending through the volume and selectively or preferentially destroy cancerous cells within the volume.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicant: LaZure Technologies, LLC
    Inventor: Larry Azure
  • Publication number: 20090076499
    Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicant: LaZure Technologies, LLC.
    Inventor: Larry Azure
  • Publication number: 20090076502
    Abstract: Methods and systems for delivering electrical energy and controlled, mild hyperthermia to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning a plurality of electrodes in a target tissue region comprising the prostate tissue, and establishing an alternating electrical current flow through a volume of the prostate tissue to induce mild heating and destruction of cancerous cells in the volume.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicants: LaZure Technologies, LLC., LaZure Scientific, Inc.
    Inventors: Larry Azure, Charles Hill, Andrew L. Azure